1. Home
  2. HSDT vs RHE Comparison

HSDT vs RHE Comparison

Compare HSDT & RHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • RHE
  • Stock Information
  • Founded
  • HSDT 2014
  • RHE 1988
  • Country
  • HSDT United States
  • RHE United States
  • Employees
  • HSDT N/A
  • RHE N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RHE Real Estate
  • Sector
  • HSDT Health Care
  • RHE Real Estate
  • Exchange
  • HSDT Nasdaq
  • RHE Nasdaq
  • Market Cap
  • HSDT 3.4M
  • RHE 2.9M
  • IPO Year
  • HSDT N/A
  • RHE 2006
  • Fundamental
  • Price
  • HSDT $0.75
  • RHE $2.29
  • Analyst Decision
  • HSDT Buy
  • RHE
  • Analyst Count
  • HSDT 2
  • RHE 0
  • Target Price
  • HSDT $24.00
  • RHE N/A
  • AVG Volume (30 Days)
  • HSDT 8.1M
  • RHE 2.2M
  • Earning Date
  • HSDT 11-12-2024
  • RHE 11-19-2024
  • Dividend Yield
  • HSDT N/A
  • RHE N/A
  • EPS Growth
  • HSDT N/A
  • RHE N/A
  • EPS
  • HSDT N/A
  • RHE N/A
  • Revenue
  • HSDT $502,000.00
  • RHE $15,753,000.00
  • Revenue This Year
  • HSDT N/A
  • RHE N/A
  • Revenue Next Year
  • HSDT $8.97
  • RHE N/A
  • P/E Ratio
  • HSDT N/A
  • RHE N/A
  • Revenue Growth
  • HSDT N/A
  • RHE N/A
  • 52 Week Low
  • HSDT $0.37
  • RHE $1.13
  • 52 Week High
  • HSDT $9.50
  • RHE $6.80
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 54.25
  • RHE 57.17
  • Support Level
  • HSDT $0.61
  • RHE $1.78
  • Resistance Level
  • HSDT $0.90
  • RHE $2.58
  • Average True Range (ATR)
  • HSDT 0.10
  • RHE 0.53
  • MACD
  • HSDT 0.00
  • RHE 0.02
  • Stochastic Oscillator
  • HSDT 48.76
  • RHE 16.33

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About RHE Regional Health Properties Inc.

Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.

Share on Social Networks: